Biotech · Public company · Charlestown, MA, US

Solid Biosciences Inc.

Ticker SLDB · SEC CIK 0001707502

Track this companyFree. Adds Solid Biosciences Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials65 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline6

SGT-003Phase 3 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
SGT-001Phase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
SGT-212Phase 1 · Friedreich's Ataxia (FA)ClinicalTrials.gov · fetched Nov 12, 2026
SGT-501Phase 1 · Catecholaminergic Polymorphic Ventricular TachycardiaClinicalTrials.gov · fetched Nov 12, 2026
Duchenne Video Assessment (DVA)Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
Wearable DeviceDuchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026

A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)PHASE1 · RECRUITING · started Feb 23, 2026ClinicalTrials.gov NCT07148089 · fetched Nov 12, 2026
A Study of SGT-212 Gene Therapy in Friedreich's AtaxiaPHASE1 · RECRUITING · started Oct 22, 2025ClinicalTrials.gov NCT07180355 · fetched Nov 12, 2026
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)PHASE3 · RECRUITING · started Oct 22, 2025ClinicalTrials.gov NCT07160634 · fetched Nov 12, 2026
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)PHASE1_PHASE2 · RECRUITING · started May 6, 2024ClinicalTrials.gov NCT06138639 · fetched Nov 12, 2026
Evaluation of Home Based Assessments on Participants With DMDCOMPLETED · started Oct 13, 2022ClinicalTrials.gov NCT05657938 · fetched Nov 12, 2026
Microdystrophin Gene Transfer Study in Adolescents and Children With DMDPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 6, 2017ClinicalTrials.gov NCT03368742 · fetched Nov 12, 2026